EICHORCondition: Heart Disease · Sponsor: Taewoong Medical Co., Ltd.
The purpose of the study is to determine the long-term follow-up clinical outcomes, effectiveness, and safety data of the PULSTA Transcatheter Pulmonary Valve (TPV) implantation in a real-world situation
This description comes directly from the study's public registry record.
Jang Mi Ko · +82 31 904 6187 · jmko@stent.net
Hyejin Roh · +82 70 4649 1624 · hjroh@stent.net
Always discuss trial participation with your own doctor first.
| Deutsches Herzzentrum München | Munich, Bavaria, Germany | — |
| Ospedale Niguarda (Milano) | Milan, Lombardy, Italy | — |
| Polish Mother's memorial hospital | Lodz, Łódź Voivodeship, Poland | — |
| Bucheon Sejong Hospital | Bucheon-si, Gyeonggi-do, South Korea | — |
| Seoul National University Hospital (Seoul) | Seoul, South Korea | — |
| Severance Hospital (Seoul) | Seoul, South Korea | — |
| La Paz Hospital (Madrid) | Madrid, Madrid, Spain | — |
| Koc University Hospital (Istanbul) | Istanbul, Istanbul, Turkey (Türkiye) | — |
| Siyami Ersek Hospital (Istanbul) | Istanbul, Istanbul, Turkey (Türkiye) | — |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07747207